Healthcare in the UK Margaret Costello – Gorlin Syndrome Group.

Slides:



Advertisements
Similar presentations
Methods of Financing Healthcare James Thompson Government Actuarys Department United Kingdom.
Advertisements

SPAIIN Where are we now?. Key concepts in clinical networks Equitable Efficient High quality Locally delivered Patient/Carer involvement ‘designed to.
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Sarita Yaganti Project Lead Service Improvement Cancer Commissioning Team West and South London.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Evolution of the MS Specialist Nurse Role. Life up to 1997 for UK MS Specialist Nurses MS nurses in post Each nurse covered an overwhelming geographical.
Experiences of Patient and Public involvement in the Research Process Roma Maguire Senior Research Fellow Cancer Care Research Team School of Nursing and.
A charity registered in England and Wales (no ) and in Scotland (no. SC039299). A company Limited by Guarantee (Number ) Genetic Alliance.
Midland Region Primary Healthcare Forum 30 May 2014.
The Voice of Carers Developing carer organisations across Europe Sebastian Fischer VOCAL - Voice of Carers Across Lothian Coalition of Carers in Scotland.
1 Developments and progress Dr Martin Freeman GP Clinical Lead for Dementia Services.
Dr Rachel McEnery GP trainer Kilmeny Group Medical Practice
Almagro 26 October 2006 Dr L J Patterson OBE MB FRCP Dr L J Patterson Consultant Physician OBE MB FRCP Quality of Care in UK National Health Service.
Castlereagh 2 nd May 2013 The Scottish Strategy for Autism.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
U.K. watchdog rejects new skin cancer drug Maria Cheng/ Associated Press
The burden of RMDs on patients and their families The value of early intervention, prevention and better management of RMDs Marios Kouloumas Chairperson.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
MIGRANT ACCESS TO HEALTHCARE – THE ISSUES Don Flynn.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
NSF for Older People Dr. Gareth Morgan NSF for Older People Project Manager.
APPRENTICESHIPS AND VALUES BASED RECRUITMENT. The Suffolk Brokerage has recently launched a new recruitment support service for adult social care employers.
The National Health Service Healthcare in the United Kingdom By Vruti Dattani University of Cambridge.
1 What is Hospice Palliative Care? The Canadian Hospice Palliative Care Association defines hospice palliative care as a special kind of health care for.
Nikki Hale Programme Manager – Competences Skills for Health Developing Competence through education and work based learning.
The Future of Rehab Working Group Jenny Pearce Chairman of Future of Rehab Working Group.
Services for people with dementia provided by Berkshire Healthcare NHS Foundation Trust Sally Cairns Joint Service Manager.
Presenter-Dr. L.Karthiyayini Moderator- Dr. Abhishek Raut
Palliative Care in the UK – now-and where are we going? Professor Mari Lloyd-Williams Professor and Director of Academic Palliative and Supportive Care.
Skin Conditions Campaign Scotland NHS 24 Tele-Dermatology User Forum November 2012 Dr Stewart Douglas, SCCS Director Skin Conditions Campaign Scotland.
District Health in South Africa Appropriate response to current health issues: How do we measure? Dr Kebogile Mokwena Department of Social and Behavioural.
Conducting Research in the UK National Health Service Dr Stephen Brett Reader In Critical Care.
Essence of Care and Links to Care Standards Jennifer Holmes.
100k Genomes Project In December 2012 the Prime Minister announced a programme of Whole Genome Sequencing as part of the UK Government’s Life Sciences.
Healthcare rationing is used by health insurers, the government and individuals to save money. Most of us believe that if there is a treatment available,
Developing a Referral Management Plan. Background Hospital referral rates in England have increased significantly over recent years, resulting in the.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
London Health Libraries 27 February Drivers for Change World Class Commissioning NHS Operating Framework Healthcare for London.
+ Role of Industry in Clinical Care, Research, and Education.
Alzheimer Scotland Dementia Post Diagnostic Support Service Edinburgh January 2014.
A charity registered in England and Wales (no ) and in Scotland (no. SC039299). A company Limited by Guarantee (Number ) Facilitating Networks.
Harvinaiset – The Finnish Network for Rare Diseases Saara Paajanen - Finnish Association of People with Physical Disabilities Pia Mölsä - The Finnish Association.
1 Information and Advice: Care Act Consultation July 2014 Carl Evans & Karen Dooley DH.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
An Introduction to Genetic Alliance UK’s Work in Scotland Natalie Frankish – Development Officer for Scotland Event:Action Duchenne Scottish Conference.
A charity registered in England and Wales (no ) and in Scotland (no. SC039299). A company Limited by Guarantee (Number ) Implementing the.
What is motor neurone disease? A fatal, rapidly progressive disease that affects the brain and spinal cord. Attacks the nerves that control movement so.
Service Triangles Mid-year Review Update January 2016.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Ethics in Clinical Genetics and Genomics Key Knowledge Year 4 Medical Ethics and Law Thread Course, The Ethox Centre, University of Oxford.
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
NURSING INFORMATICS IN CANADA. BRIEF HISTORY Nursing informatics began to evolve as nurses participated in the early initiatives in hospital information.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
The guiding principles of prudent healthcare
Romanian Rare Cancers Association – RCArare Darkó Emese
Metastatic Breast Cancer (MBC) Challenge
(95% confidence interval)
Healthcare and Medicine in the UK
Health Education England Workforce Strategy - Key Points
Achieving World-Class Cancer Outcomes A Strategy for England
Specialised Commissioning Improving specialised services for severe intestinal failure adult patients What will this mean for you?
Achieving World-Class Cancer Outcomes A Strategy for England
Health Education England Workforce Strategy - Key Points
Achieving World-Class Cancer Outcomes A Strategy for England
(95% confidence interval)
January 2019 ROSC Seminar.
Wendy Levinson, MD Professor of Medicine, University of Toronto
National Confidential Enquiry into Patient Outcome and Death ‘For better, for worse’ and the End of Life Care Strategy Dr Teresa Tate FRCP FRCR Medical.
Squamous cell carcinoma pathway update
Presentation transcript:

Healthcare in the UK Margaret Costello – Gorlin Syndrome Group

Healthcare in the UK The National Health Service NHS All UK residents Free at the point of need Paid from taxation + Private Health Plans

NHS – a brief history  Came into existence on 5 th July 1948  Financial restrictions of a centrally funded service  Advances in medical knowledge, medicine and technology  People living longer  Re-organisation – a constant  In recognition of the deficiencies of the service  1978 – 30 th anniversary of the NHS  1989 – huge injection of cash and the NHS Review  National Health Service Reform and Health Care Professions Act  Lord Darzi’s Report – Next Stage Review 2008  Patient and Public Involvement / Consultation  Patient led NHS

Gorlin Syndrome – patient feedback  Negative feedback throughout the 1990s  Long term medical condition requiring regular monitoring and timely treatment  Delays in diagnosis and treatment  Waiting lists and access to services  Inequality of services - post code lottery!  Choice?

Campaigning on behalf of patients  National Voices  previously Long Term Conditions Alliance  Skin Care Campaign  England, Northern Ireland, Scotland and Wales  Genetics Interest Group (GIG)  Rare genetic conditions  Rare Disease UK  Rare Disease launch coincided with Rare Disease Day 2009 “6000 rare diseases affecting over 3.5 million people (1 in 17) in the UK. NHS services to support people with rare diseases remain patchy and poorly integrated, meaning that thousands of UK families with rare diseases struggle to access the help and support they need”

Rare Disease Action Plan  How will this benefit the UK? A National Strategy for integrated service delivery for families affected by rare disease would aim to create efficiency in expenditure and service allocation. Aims:  help to make the most efficient use of the limited NHS resources available;  support the Government’s health research agenda, including strengthening translational research;  facilitate early and correct diagnosis and timely treatment, which could offer improved health and quality of life for people with rare diseases;  ensure the UK keeps pace with other EU countries that have adopted national plans on rare disease.

Breakthrough - NICE Guidelines  National Institute of Clinical Excellence (NICE)  Good practice guidelines for healthcare professionals  Consultation  Patient and Public Involvement  Improving Outcomes for People with Skin Tumours including Melanoma  Patients who need specialist diagnosis should be referred to a doctor trained to diagnose skin cancer  Skin cancer teams should work to agreed protocols  Protocols should cover the management of care for people in high-risk or special groups (Gorlin Syndrome)  Follow-up care plans

Progress  Improvements to date  Shorter waiting lists  Improved access to services and treatments  Choice  Multi disciplinary teams for care of long term conditions  Review of prescription charges  Cancer patients  Exemption from prescriptions charges for all cancer patients with effect from April 2009  Patients with long term medical conditions  Currently under review but probable that exemption from prescription charges will come into effect April 2010

Patient feedback now  Recent feedback from GS patients  Early diagnosis still a problem for some (more about the condition than the NHS)  It seems less of a battle to gain access to services and to timely and appropriate treatment  More research is definitely needed – it is pleasing to see advances are being made but a long way to go!  Things have moved on although some services still patchy  It all feels much more patient focussed than ever before

Looking to the future  Maintain improvements in service delivery  Centres of excellence  Equality and choice  Rare Disease Action Plan  Fully integrated services to support people with rare diseases  Early and correct diagnosis and timely treatment  Research  Clinical trials  Appears to be little going on in the UK for rarer conditions

GSG – Our future role  Maintain and further develop links with  Medical advisors  British Association of Dermatologists  Other disciplines  Ensure Gorlin Syndrome remains ‘on the map’  Continue to raise awareness and ensure patient need is met  Promote research  Into the various aspects of the condition  And lastly but not least  Continue supporting patients and their families affected by Gorlin Syndrome